Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Cosman, Felicia, Crittenden, Daria B., Adachi, Jonathan D., Binkley, Neil, Czerwinski, Edward, Ferrari, Serge, Hofbauer, Lorenz C., Lau, Edith +9 more·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1607948

Cited by (1,001)

Items 301–400 of 1,001

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
Denise Toscani, Marina Bolzoni, Marzia Ferretti, Carla Palumbo, Nicola Giuliani · 2018 · Frontiers in Immunology
Mesenchymal Cell-Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation
Fan Wang, Kati M. Tarkkonen, Vappu Nieminen-Pihala, Kenichi Nagano, Rana Al Majidi, Tero Puolakkainen, Petri Rummukainen, Jemina Lehto, Anne Roivainen, Fuping Zhang et al. · 2019 · Journal of Bone and Mineral Research
Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial
Felicia Cosman, Linda R. Peterson, Dwight A. Towler, Bruce Mitlak, Yamei Wang, Steven Ron Cummings · 2020 · The Journal of Clinical Endocrinology & Metabolism
Osteoporosis in children and adolescents: how to treat and monitor?
Silvia Ciancia, Wolfgang Högler, Ralph J. B. Sakkers, Natasha M. Appelman‐Dijkstra, Annemieke M. Boot, Theo Sas, Judith S. Renes · 2022 · European Journal of Pediatrics
Connecting Bone and Fat: the Potential Role for Sclerostin
Heather E. Fairfield, Clifford james Rosen, Michaela Ruth Reagan · 2017 · Current Molecular Biology Reports
The emerging role of bone marrow adipose tissue in bone health and dysfunction
Thomas H. Ambrosi, Tim Julius Schulz · 2017 · Journal of Molecular Medicine
Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice
Thomas Funck‐Brentano, Karin H Nilsson, Robert Brommage, Petra Henning, Ulf H. Lerner, Antti Koskela, Juha Tuukkanen, Martine Esther Cohen-Solal, Sofia Movérare‐Skrtic, Claes Ohlsson · 2018 · Journal of Endocrinology
Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis
Miller, Shannon A., St. Onge, Erin Lyn, Whalen, Karen L. · 2021 · Journal of Pharmacy Technology
A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease
Geeta Hampson, Grahame J. Elder, Martine Esther Cohen-Solal, Bo Abrahamsen · 2021 · Endocrine
Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing
Yevgeniya S. Kushchayeva, Iryna Pestun, Sergiy V. Kushchayev, Nataliia Radzikhovska, Edward Michael Lewiecki · 2022 · Journal of Clinical Medicine
Impact of aging on bone, marrow and their interactions
Corey M. Hoffman, Jimin Han, Laura Maria Calvi · 2018 · Bone
Regulatory mechanisms of sclerostin expression during bone remodeling
Masanori Koide, Yasuhiro Kobayashi · 2018 · Journal of Bone and Mineral Metabolism
Management of primary and secondary osteoporosis in children
Sophia D. Sakka, Moira Cheung · 2020 · Therapeutic Advances in Musculoskeletal Disease
Management of glucocorticoid-induced osteoporosis
Osvaldo Daniel Messina, Luis Fernando Vidal, Maritza Vidal, Irene E. M. Bultink, Hennie G. Raterman, William F Lems · 2021 · Aging Clinical and Experimental Research
Bone circuitry and interorgan skeletal crosstalk
Zaidi, Mone, Kim, Se-Min, Mathew, Mehr, Korkmaz, Funda, Sultana, Farhath, Miyashita, Sari, Gumerova, Anisa Azatovna, Frolinger, Tal, Moldavski, Ofer, Barak, Orly et al. · 2023 · eLife
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study
Giovanni Adami, Elisa Pedrollo, Maurizio Rossini, Angelo Fassio, V. Braga, Emma Pasetto, Francesco Pollastri, Camilla Benini, Ombretta Viapiana, Davide Gatti · 2024 · JBMR Plus
Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency–induced bone loss
Chike Cao, Yinshi Ren, Adam S. Barnett, Anthony J. Mirando, Douglas C. Rouse, Se Hwan Mun, Kyung‐Hyun Park‐Min, Amy L. McNulty, Farshid Guilak, Courtney M. Karner et al. · 2017 · JCI Insight
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a <scp>Genome‐Wide</scp> Association <scp>Meta‐Analysis</scp> Followed by Mendelian Randomization
Zheng, Jie, Wheeler, Eleanor, Pietzner, Maik, Andlauer, Till F. M., Yau, Michelle S., Hartley, April E., Brumpton, Ben Michael, Rasheed, Humaira, Kemp, John P., Frysz, Monika et al. · 2023 · Arthritis & Rheumatology
One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
Tomohiro Saito, Masahide Mizobuchi, Tadashi Kato, Taihei Suzuki, Yasuro Fujiwara, Naoaki Kanamori, Mikio MAKUUCHI, Hirokazu Honda · 2022 · Calcified Tissue International
Recent advances in the management of osteoporosis
Seiji Fukumoto, Toshio Matsumoto · 2017 · F1000Research
New agents in the Treatment of Myeloma Bone Disease
Elizabeth S. Ring, Michelle Anne Lawson, John Andrew Snowden, Ingrid Jolley, Andrew Chantry · 2017 · Calcified Tissue International
Addressing the crisis in the treatment of osteoporosis
Christian Roux, Karine Briot · 2018 · Nature Reviews Rheumatology
Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta
Mickaël Cardinal, Janne Tys, Thomas Roels, Sébastien Lafont, Michael S. Ominsky, Jean‐Pierre Devogelaer, Daniel Chappard, Guillaume Mabilleau, Patrick Ammann, Catherine Behets et al. · 2019 · Bone
Focal adhesion proteins Pinch1 and Pinch2 regulate bone homeostasis in mice
Yishu Wang, Qinnan Yan, Yiran Zhao, Xin Zhe Liu, Simin Lin, Peijun Zhang, Li‐Ting Ma, Yumei Lai, Xiaochun Bai, C.-J. Liu et al. · 2019 · JCI Insight
Treatment options for glucocorticoid-induced osteoporosis
Iacopo Chiodini, Daniela Merlotti, Alberto Falchetti, Luigi Gennari · 2020 · Expert Opinion on Pharmacotherapy
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
Yao Yao, Frederic Kauffmann, Shogo Maekawa, Lea Sarment, James V. Sugai, Caroline Schmiedeler, Edward J. Doherty, Gill Holdsworth, Paul J. Kostenuik, William V. Giannobile · 2020 · Scientific Reports
Bioactivity, Molecular Mechanism, and Targeted Delivery of Flavonoids for Bone Loss
Ashish Ranjan Sharma, Yeon‐Hee Lee, Altanzul Bat-Ulzii, Srijan Chatterjee, Manojit Bhattacharya, Chiranjib Chakraborty, Sang‐Soo Lee · 2023 · Nutrients
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health
Paul J. Kostenuik, Neil Binkley, Paul A. Anderson · 2023 · Current Osteoporosis Reports
New anabolic therapies for osteoporosis
Salvatore Minisola, Cristiana Cipriani, Marco Occhiuto, Jessica Pepe · 2017 · Internal and Emergency Medicine
Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)
Nicola Napoli, Bente Lomholdt Langdahl, Östen Ljunggren, Éric Lespessailles, George A. Kapetanos, Tomaž Kocjan, Tatjana Nikolic, Pia Eiken, Helmut Petto, Thomas Moll et al. · 2018 · Calcified Tissue International
New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)
Aylin Sepici Dinçel, Niklas Rye Jørgensen · 2022 · Calcified Tissue International
Why Animal Experiments Are Still Indispensable in Bone Research: A Statement by the European Calcified Tissue Society
Stein, Merle, Elefteriou, Florent, Busse, Björn, Fiedler, Imke AK, Kwon, Ronald Young, Farrell, Eric, Ahmad, Mubashir, Ignatius, Anita, Grover, Liam, Geris, Liesbet et al. · 2023 · Journal of Bone and Mineral Research
Radiation-Induced Osteocyte Senescence Alters Bone Marrow Mesenchymal Stem Cell Differentiation Potential via Paracrine Signaling
Linshan Xu, Yuyang Wang, Jianping Wang, Jianglong Zhai, Li Ren, Guoying Zhu · 2021 · International Journal of Molecular Sciences
LRP5: From bedside to bench to bone
Bart O. Williams · 2017 · Bone
The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease
Takahiro Makino, Hiroyuki Tsukazaki, Yuichiro Ukon, Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito · 2018 · International Journal of Molecular Sciences
Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
S. Vallet, Julia-Marie Filzmoser, M. Pecherstorfer, K. Podar · 2018 · Pharmaceutics
Balancing benefits and risks in the era of biologics
Giovanni Adami, Kenneth G. Saag, Roland D Chapurlat, Núria Guañabens, Glenn Haugeberg, Willem Frederik Lems, Radmila Matijević, Nicola F. A. Peel, Denis Poddubnyy, Piet Geusens · 2019 · Therapeutic Advances in Musculoskeletal Disease
Update on Glucocorticoid Induced Osteoporosis
Soo‐Kyung Cho, Yoon‐Kyoung Sung · 2021 · Endocrinology and Metabolism
Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
Jing Peng, Hui Wang, Zhen Liu, Xu Zhenliang, Meixia Wang, Qi-Miao Chen, Mingli Wu, Xiaolei Ren, Qiu-Hua Liang, Fupeng Liu et al. · 2022 · Frontiers in Pharmacology
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls
Lisa Lungaro, Francesca Manza, Anna Costanzini, Marianna Barbalinardo, Denis Gentili, Fabio Caputo, Matteo Guarino, Giorgio Zoli, Umberto Volta, Roberto DE GIORGIO et al. · 2023 · Nutrients
Recommendations for the optimal use of bone forming agents in osteoporosis
Nicola Veronese, Karine Briot, Núria Guañabens, Ben Hur Albergaria, Majed Saleh Alokail, Nasser M. Al‐Daghri, Angie Botto‐van Bemden, Olivier Bruyère, Nansa Burlet, Cyrus C. Cooper et al. · 2024 · Aging Clinical and Experimental Research
Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults
Paul Glendenning, Stephen A. Paul Chubb, Samuel D Vasikaran · 2018 · Clinica Chimica Acta
The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study
Piet Geusens, Mary K. Oates, Akimitsu Miyauchi, Jonathan Derrick Adachi, Marise Lazaretti‐Castro, Peter Robert Ebeling, Carlos Augusto Pérez Niño, Cassandra E. Milmont, Andreas Grauer, Cesar R. Libanati · 2019 · JBMR Plus
Role of bone-forming agents in the management of osteoporosis
Michael R. McClung · 2021 · Aging Clinical and Experimental Research
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Lisha Sun, Yixiao Zhang, Guanglei Chen, Yaoting Ji, Qingtian Ma, Xinbo Qiao, Sijin Wu, Lin Mei Zhou, Jiawen Bu, Xudong Zhu et al. · 2022 · Molecular Cancer
Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis
Kosuke Ebina, Yuki Etani, Takaaki Noguchi, Ken Nakata, Seiji Okada · 2024 · Journal of Bone and Mineral Metabolism
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation
Eveline Boudin, Wim Van Hul · 2017 · European Journal of Endocrinology
Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?
Felicia Cosman, David W. Dempster · 2021 · Current Osteoporosis Reports
The Pathophysiology of Osteoporosis after Spinal Cord Injury
Ramsha Shams, Kelsey P. Drasites, Vandana Zaman, Denise D Matzelle, Donald C. Shields, Dena P. Garner, Christopher J. Sole, Azizul Haque, Naren Lal Banik · 2021 · International Journal of Molecular Sciences
Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?
Christian Horst Tonk, Sarah Hani Shoushrah, Patrick Babczyk, Basma El Khaldi-Hansen, Margit Schulze, Monika Herten, Edda Tobiasch · 2022 · International Journal of Molecular Sciences
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus
Silvia Marino, Teresita Bellido · 2024 · Nature Reviews Endocrinology
Drug-induced osteonecrosis of the jaw: the state of the art
Angelo Fassio, Francesco Bertoldo, Luca Idolazzi, Ombretta Viapiana, Maurizio Rossini, Davide Gatti · 2017 · Reumatismo
The Non-invasive Diagnosis of Bone Disorders in CKD
Jordi Bover, Pablo Ureña, Mario Gennaro Cozzolino, Minerva Rodríguez-García, Carlos Gómez‐Alonso · 2021 · Calcified Tissue International
Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis
Xiaodong Li, Michael S. Ominsky, Kelly S Villasenor, Qing‐Tian Niu, Frank Asuncion, Xuechun Xia, Mario S. Grisanti, Thomas J. Wronski, W. Scott Simonet, Hua Zhu Ke · 2017 · Endocrinology
Prevention and treatment of osteoporosis in women
John C. Stevenson, in collaboration with the medical advisory council of the British Menopause Society · 2022 · Post Reproductive Health
Using Osteoporosis Therapies in Combination
Michael R. McClung · 2017 · Current Osteoporosis Reports
Sclerostin Neutralizing Antibody Treatment Enhances Bone Formation but Does Not Rescue Mechanically Induced Delayed Healing
Bettina Kruck, Elizabeth A. Zimmermann, Sophie Damerow, Christine Figge, Catherine Julien, Dag Wulsten, Tobias Thiele, Madge Martin, Reggie Charles Hamdy, Marie Karolina Reumann et al. · 2018 · Journal of Bone and Mineral Research
Risk factors for subsequent vertebral fracture after acute osteoporotic vertebral fractures
Hiroyuki Inose, Tsuyoshi Kato, Shoichi Ichimura, Hiroaki Nakamura, Masatoshi Hoshino, Daisuke Togawa, Tôru Hirano, Yasuaki Tokuhashi, Tetsuro Ohba, Hirotaka Haro et al. · 2021 · European Spine Journal
Marrow Adipose Tissue: Its Origin, Function, and Regulation in Bone Remodeling and Regeneration
Qiwen Li, Yunshu Wu, Ning Kang · 2018 · Stem Cells International
RNA-based therapy for osteogenesis
Pinpin Wang, Federico Perche, Delphine Logeart‐Avramoglou, Chantal Pichon · 2019 · International Journal of Pharmaceutics
Practical guidance for the use of bisphosphonates in osteoporosis
Juliet Elizabeth Compston · 2020 · Bone
Biological and Clinical Aspects of Metastatic Spinal Tumors
Jakub Litak, Wojciech Czyżewski, Michał Szymoniuk, Leon Sakwa, Barbara Pasierb, Joanna Litak, Zofia Hoffman, Piotr Kamieniak, Jacek Roliński · 2022 · Cancers
Romosozumab Treatment in Postmenopausal Osteoporosis
Felicia Cosman, Daria B Crittenden, Andreas Grauer · 2017 · New England Journal of Medicine
Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines
Elpiniki Rentzeperi, Stavroula Pegiou, Ioannis G. Tsakiridis, Ioannis A Kalogiannidis, Anargyros Kourtis, Apostolos M. Mamopoulos, Apostolos P Athanasiadis, Themistoklis Dagklis · 2023 · Obstetrical & Gynecological Survey
A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease
Asim Rahman, Md. Faheem Haider · 2024 · Steroids
Romosozumab: a novel bone anabolic treatment option for osteoporosis?
Katharina Kerschan‐Schindl · 2019 · Wiener Medizinische Wochenschrift
Cardiovascular Safety of Denosumab Across Multiple Indications: A Systematic Review and Meta-Analysis of Randomized Trials
Alexander Henry Seeto, Bo Abrahamsen, Peter Robert Ebeling, Alexander J. Rodríguez · 2020 · Journal of Bone and Mineral Research
Artesunate promotes osteoblast differentiation through miR-34a/DKK1 axis
Hanbing Zeng, Liqiang Dong, Chao Xu, Xuhui Zhao, Lian-Guo Wu · 2020 · Acta Histochemica
Perspectives on the Genetic Associations of Ankylosing Spondylitis
B. P. Wordsworth, C. Cohen, Connor Davidson, Matteo L. Vecellio · 2021 · Frontiers in Immunology
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration
Tomonori Kobayakawa, Akiko Miyazaki, Yasuhide Kanayama, Yuji Hirano, Jun A. Takahashi, Takako Suzuki, Yukio Nakamura · 2022 · Modern Rheumatology
Sclerostin: From Molecule to Clinical Biomarker
Ahmed Shaker Omran, Diana Atanasova, Filip Landgren, Per Magnusson · 2022 · International Journal of Molecular Sciences
Recommendations on the post-acute management of the osteoporotic fracture - Patients with “very-high” Re-fracture risk
Ronald Man Yeung Wong, Wing‐Hoi Cheung, Simon Kwoon‐Ho Chow, Raymond Wai Kit Ng, Wilson Li, Hsu Albert Yung-Chak, Kam Kwong Wong, Angela WH Ho, Shing-Hing Choi, Christian Xinshuo Fang et al. · 2022 · Journal of Orthopaedic Translation
Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
Shih‐Hao Cheng, William Chu, Wen-Hsiang Chou, Woei‐Chyn Chu, Yi‐No Kang · 2024 · Drug Safety
Novel Therapies for Postmenopausal Osteoporosis
Leonardo Bandeira, John Paul Bilezikian · 2016 · Endocrinology and Metabolism Clinics of North America
Advanced glycation end-product 2 and Porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells
Eijiro Sakamoto, Jun‐ichi Kido, Ryosuke Takagi, Yuji Inagaki, Koji Naruishi, Toshihiko Nagata, Hiromichi Yumoto · 2019 · Bone
Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial
Junichi Takada, Rajani V. Dinavahi, Akimitsu Miyauchi, Etsuro Hamaya, Toshiyasu Hirama, Cesar R. Libanati, Yoichi Nakamura, Cassandra E. Milmont, Andreas Grauer · 2019 · Journal of Bone and Mineral Metabolism
Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review
Shakeri, Ahmad, Adanty, Christopher · 2020 · Journal of Population Therapeutics & Clinical Pharmacology
Effect of Low-Intensity Vibration on Bone Strength, Microstructure, and Adiposity in Pre-Osteoporotic Postmenopausal Women: A Randomized Placebo-Controlled Trial
Chamith S. Rajapakse, Alyssa Johncola, Alexandra S. Batzdorf, Brandon C. Jones, Mona Al Mukaddam, Kelly Sexton, Justine Shults A, Mary Beth Leonard, Peter J. Snyder, Felix Werner Wehrli · 2020 · Journal of Bone and Mineral Research
The effect of parathyroid hormone on osteogenesis is mediated partly by osteolectin
Jingzhu Zhang, Adi Cohen, Bo Shen, Liming Du, Alpaslan Tasdogan, Zhiyu Zhao, Elizabeth J. Shane, Sean J. Morrison · 2021 · Proceedings of the National Academy of Sciences
Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials
Adrián Vladimir Hernández, Faustino Ramón Pérez-López, Alejandro Piscoya, Vinay Pasupuleti, Yuani M. Roman, Priyaleela Thota, Antonio Herrera · 2019 · Maturitas
Functional and analytical recapitulation of osteoclast biology on demineralized bone paper
Yongkuk Park, Tadatoshi Sato, Jungwoo Lee · 2023 · Nature Communications
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Shejil Kumar, Matti L. Gild, Michelle Maree McDonald, Albert S. Kim, Roderick John Clifton-Bligh, Christian M. Girgis · 2024 · Osteoporosis International
Recent Advances in Osteoporosis Therapeutics
Anne Sophie Sølling, Bente Lomholt Langdahl, Felicia Cosman · 2025 · Annual Review of Medicine
Denosumab for the treatment of osteoporosis
Michael R. McClung · 2017 · Osteoporosis and Sarcopenia
Site specific measurements of bone formation using [18F] sodium fluoride PET/CT
Glen Mervyn Blake, Tanuj Puri, Musib M. Siddique, Michelle L. Frost, Amelia E.B. Moore, Ignac Fogelman · 2018 · Quantitative Imaging in Medicine and Surgery
Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: A critical assessment of the mechanism of action
Sharmistha Bhattacharyya, Subhashis Pal, Naibedya Chattopadhyay · 2018 · European Journal of Pharmacology
Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice
Kelsey A. Carpenter, Ryan D. Ross · 2019 · Journal of Bone and Mineral Research
Thyroid Hormone Actions and Bone Remodeling – The Role of the Wnt Signaling Pathway
Franziska Lademann, Elena A. Tsourdi, Lorenz Christian Hofbauer, Martina Rauner · 2020 · Experimental and Clinical Endocrinology & Diabetes
Identification of osteogenic progenitor cell-targeted peptides that augment bone formation
Min Jiang, Ruiwu Liu, Lixian Liu, Alexander Kot, Xueping Liu, Wenwu Xiao, Junjing Jia, Yuanpei Li, Kit S. Lam, Wei Yao · 2020 · Nature Communications
The therapeutic potential of mesenchymal stem cells in treating osteoporosis
Tianning Chen, Tieyi Yang, Weiwei Zhang, Jin Shao · 2021 · Biological Research
Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis
Núria Martínez‐Gil, Nerea Ugartondo, Daniel Grinberg, Susana Balcells · 2022 · Genes
Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
Sian Yik Lim · 2022 · Women s Health
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models
Julia Paton‐Hough, Simon J. Tazzyman, Holly Evans, Darren Lath, Jenny M. Down, Alanna C. Green, John Andrew Snowden, Andrew Chantry, Michelle Anne Lawson · 2018 · Journal of Bone and Mineral Research
Closing the gap in osteoporosis management: the critical role of primary care in bone health
Andrea J. Singer, Anita K. Sharma, Cynthia Deignan, Liesbeth A.D. Borgermans · 2023 · Current Medical Research and Opinion
Novel insights on the effect of sclerostin on bone and other organs
Timothy J. Dreyer, Jacob A. C. Keen, Leah M. Wells, Scott J. Roberts · 2023 · Journal of Endocrinology
Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials
Takaomi Kobayashi, Tadatsugu Morimoto, Koji Ito, Masaaki Mawatari, Takafumi Shimazaki · 2024 · Osteoporosis International
Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approach
Olivier Lamy, Judith Everts‐Graber, Elena González Rodríguez · 2025 · Aging Clinical and Experimental Research
Osteoporosis: molecular pathogenesis and therapeutic interventions
Xubin Zhang, Yongsheng Liang, Fayao Zhang, Xiaoyuan Liu · 2025 · Molecular Biomedicine
Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading
Alyson Morse, Aaron Schindeler, Michelle Maree McDonald, Michaela Kneissel, Ina Krämer, David Graham Little · 2017 · Journal of Bone and Mineral Research
Osteoporosis, densidad mineral ósea y complejo CKD-MBD (II): implicaciones terapéuticas
Jordi Bover, Pablo Ureña, Ana María Láiz, José‐Vicente Torregrosa, Minerva Rodríguez-García, Cristina Castro-Alonso, José Luis Górriz, Silvia Benito, Víctor López‐Báez, María Jesús Lloret Cora et al. · 2019 · Nefrología